SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cell Therapeutics (CTIC)
An SI Board Since August 1997
Posts SubjectMarks Bans Symbol
946 45 0 CTIC
Emcee:  Regis McConnell Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
296Here's hoping that Punk Ziegel is being conserative with their price target.Ian@SI-11/15/2004
295Jim McCamant's Medical Technology newsletter recently published a review andSidney Street-11/15/2004
294Phase II Study of CT-2103 in Patients With Recurrent Epithelial Ovarian, FallopiIcebrg-11/13/2004
293Message 20750123 Message 20750402keokalani'nui-11/9/2004
292>>SEATTLE, Nov. 9 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) tuck-11/9/2004
291Well over 30 abstracts at ASH (thanks for posting the link, Erik) concerning Arstuck-11/5/2004
290Study of arsenic trioxide-induced vascular shutdown and enhancement with radiatiIcebrg-11/5/2004
289>>I guess you have to look at when the article was first submitted>>Icebrg-11/4/2004
288I guess you have to look at when the article was first submitted - that might haBiomaven-10/27/2004
287CT-2103: emerging utility and therapy for solid tumours. Expert Opin Investig DIcebrg-10/27/2004
286CEO Bianco repays loan from Cell Therapeutics [The local press reports on BiancIcebrg-10/26/2004
285<i>torsade de pointes</i> My medical ignorance - if you had shown mtom pope-10/25/2004
284Nippon Shinyaku Co., Ltd. Receives Approval to Market TRISENOX(R) in Japan scaram(o)uche-10/25/2004
283Bianco's loan from CTIC From 8-k filed today. Item 8.01. Other Events. OnIcebrg-10/25/2004
282Molecular remission with arsenic trioxide in patients with newly diagnosed acuteIcebrg-10/13/2004
281Study of arsenic trioxide-induced vascular shutdown and enhancement with radiatiIcebrg-10/8/2004
280Trolox selectively enhances arsenic-mediated oxidative stress and apoptosis in AIcebrg-10/7/2004
279An efficient therapeutic approach to patients with acute promyelocytic leukemia Icebrg-10/7/2004
278Phase I study of CT2106 (polyglutamate camptothecin) in patients with advanced mIcebrg-9/30/2004
277Arsenic may have role in leukaemia treatment [Nothing new here really, apart frIcebrg-9/29/2004
276Some notes from the UBS cc. Message 20571402 as well as the following message. Icebrg-9/27/2004
275Feuerstein on Dacogen (treatment of MDS). It is not at all clear to me whether DIcebrg-9/8/2004
274Channelling the Emperor: what really killed Napoleon? Mari F, Bertol E, FinIcebrg-9/2/2004
273Drug uptake and pharmacological modulation of drug sensitivity in leukemia by AQIcebrg-9/2/2004
272Cell Therapeutics, Inc. Announces Exercise of Underwriters' Common Stock OveIcebrg-8/31/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News